- Home
- News and Media
- Press Releases
-
The College of American Pathologists (CAP), the International Association for the Study of Lung Cancer (IASLC), and the Association for Molecular Pathology (AMP) announced the open comment period for “Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors.”
-
Rapid progress in understanding the impact that the human papillomavirus (HPV) has on head and neck cancers is driving development of the College of American Pathologists (CAP) newest evidence-based practice guideline, “High Risk Human Papillomavirus (HPV) Testing for Head and Neck Cancers,” which is available today in draft form for public comment through August 8, 2016 on cap.org.
-
-
-
As part of the organization’s ongoing efforts to educate policy influencers—members of Congress, congressional staff, regulatory agency officials, and health policy experts—the College of American Pathologists (CAP) is continuing an advertisement campaign with new ads at Ronald Reagan Washington National Airport (DCA).